Clinical evidence exists, in a national literature most readers cannot independently verify

We are an affiliate: if you order from Growth Guys using this code we earn a commission, at no extra cost to you. We are not Growth Guys and have no ownership of or role in the company.

Selank was developed in Russia and has clinical status there. This is unusual in this index: the evidence is not absent, it sits in a regulatory and publication system separate from the one most readers can check.

Developed and used in one country

Selank was developed in Russia and has clinical status there. This is unusual in this index: the evidence is not absent, it sits in a regulatory and publication system separate from the one most readers can check.

Why that is a real limitation and not a dismissal

Trials conducted elsewhere are not thereby invalid. The practical problem is verification: many reports are not indexed in the databases a reader would search, are published in Russian, and were reviewed under a process whose standards are harder to assess from outside. 'Clinically used' is accurate and unverifiable at the same time.

Secondary summaries magnify the problem

English-language descriptions usually cite reviews that cite the original work. Each step loses the ability to check the method, and claims firm up as they travel. If a reader cannot reach the primary report, the correct confidence is lower than the summary conveys.

What the assay contributes

Identity and purity of the supplied material, which is the one part of the picture that can be independently confirmed regardless of where the clinical literature sits.

Stating it accurately

A compound with genuine clinical history in one country, limited independent verification elsewhere, and a published assay record here. All three facts belong in the same sentence.

The published record for this item

The published set we counted contains 6 report(s) naming selank, averaging 99.8% purity. Each resolves on the testing laboratory's own portal rather than as a file hosted by the seller.

Small trials in one setting

Where the human evidence consists of small studies conducted largely in one country, consistency between them is weaker evidence than it looks, because shared methods and shared assumptions can produce shared errors.

What would change the picture

Independent replication in a different research culture, with pre-registered endpoints. Until that exists the honest summary is that the evidence is suggestive and narrow, which is a more useful statement than either dismissal or endorsement.

Duration is the common limitation

Short studies cannot detect effects that take longer to appear, in either direction. A literature consisting mainly of brief trials is silent about longer use, which is usually the question a reader actually has.

Where to check this independently

The claims on this page about clinical evidence exists, in a national literature most readers cannot independently verify can be checked against sources outside this site:

HEALTHYLIFE10 — 10% off everything at growthguys.com, no minimum purchase, no product carve-outs. The record of every check is public at the evidence index; the full code page explains how the checks are run.

Related